Cargando…

Platelet-leukocyte aggregate is associated with adverse events after surgical intervention for rheumatic heart disease

Platelet-leukocyte aggregate (PLA) is implicated in the etiology of both vascular lesions and cardiovascular events. This prospective cohort study aimed to examine the prognostic value of PLA for major adverse cardiac and cerebrovascular events (MACCE) and perioperative adverse events (AEs) in patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chaonan, Yang, Yang, Du, Lei, Chen, Si, Zhang, Jie, Zhang, Chongwei, Zhou, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737193/ https://www.ncbi.nlm.nih.gov/pubmed/31506454 http://dx.doi.org/10.1038/s41598-019-49253-3

Ejemplares similares

Platelet-leukocyte aggregates – a predictor for acute kidney injury after cardiac surgery
por: Yang, Shenghan, et al.
Publicado: (2021)

Measuring and interpreting platelet-leukocyte aggregates
por: Finsterbusch, Michaela, et al.
Publicado: (2018)

Management of immune checkpoint inhibitor‐related rheumatic adverse events
por: Zhou, Jiaxin, et al.
Publicado: (2019)

Platelet Activation and Platelet–Leukocyte Aggregates in Type I Diabetes Mellitus
por: Zahran, Asmaa M., et al.
Publicado: (2018)

Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy
por: Arvanitidis, Efthymios, et al.
Publicado: (2017)

Activated platelets and platelet-leukocyte aggregates in the equine systemic inflammatory response syndrome
por: Theuerkauf, Kim, et al.
Publicado: (2022)

A Potential Role of Vitamin D on Platelet Leukocyte Aggregation and Pathological Events in Sepsis: An Updated Review
por: Alharbi, Azzah
Publicado: (2021)

Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
por: Xiao, Yan, et al.
Publicado: (2020)

Long-Term Leukocyte Filtration Should Be Avoided during Extracorporeal Circulation
por: Tang, Jiali, et al.
Publicado: (2013)

Gallic Acid Attenuates Platelet Activation and Platelet-Leukocyte Aggregation: Involving Pathways of Akt and GSK3β
por: Chang, Shih-Sheng, et al.
Publicado: (2012)

Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events
por: Mathias, Kristen, et al.
Publicado: (2023)

The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans
por: Auckland, Kathryn, et al.
Publicado: (2020)

Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
por: Rodríguez, Sandra, et al.
Publicado: (2020)

Rheumatic immune‐related adverse events induced by immune checkpoint inhibitors
por: Zhong, Hui, et al.
Publicado: (2020)

Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation
por: Mansour, Alexandre, et al.
Publicado: (2020)

Mining Patterns of Adverse Events Using Aggregated Clinical Trial Results
por: Luo, Zhihui, et al.
Publicado: (2013)

Prognostic value of hypoalbuminemia for adverse outcomes in patients with rheumatic heart disease undergoing valve replacement surgery
por: Wei, Xue-biao, et al.
Publicado: (2017)

Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
por: Manzo, Ciro
Publicado: (2021)

Transcatheter heart valve interventions for patients with rheumatic heart disease
por: Weich, Hellmuth, et al.
Publicado: (2023)

Leukocyte subtypes and adverse clinical outcomes in patients with acute ischemic cerebrovascular events
por: Wang, Anxin, et al.
Publicado: (2021)

Retrospective Evaluation of Platelet-Leukocyte Indices and Cardiac Surgical Outcomes in Acyanotic Heart Disease Patients with Pulmonary Hypertension (REPLICA-PH)
por: Walian, Ashish, et al.
Publicado: (2022)

Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates
por: Slingsby, Martina H. Lundberg, et al.
Publicado: (2021)

Platelets’ morphology, metabolic profile, exocytosis, and heterotypic aggregation with leukocytes in relation to severity and mortality of COVID-19-patients
por: Yasseen, Basma A., et al.
Publicado: (2022)

Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy
por: Bobircă, Anca, et al.
Publicado: (2021)

Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors
por: Zeng, Li, et al.
Publicado: (2023)

Effect of Desmopressin on Platelet Aggregation and Blood Loss in Patients Undergoing Valvular Heart Surgery
por: Jin, Lei, et al.
Publicado: (2015)

Inhibitory Effect of Propolis on Platelet Aggregation In Vitro
por: Zhang, Yun-Xiang, et al.
Publicado: (2017)

Leukocyte Telomere Length Shortening Implies Plaque Instability and Major Adverse Cardiovascular Events in Patients With Angiographically Intermediate Lesions
por: Zhang, Alian, et al.
Publicado: (2022)

Composition of Platelet-Rich Plasma Prepared From Knee Osteoarthritic Patients: Platelets, Leukocytes, and Subtypes of Leukocyte
por: Turajane, Thana, et al.
Publicado: (2023)

Leukocyte- and platelet-rich fibrin as an adjuvant to the surgical approach for osteoradionecrosis: a case report
por: Maluf, Gustavo, et al.
Publicado: (2020)

Leukocyte-Rich Platelet-Rich Plasma Has Better Stimulating Effects on Tenocyte Proliferation Compared With Leukocyte-Poor Platelet-Rich Plasma
por: Lin, Keng-Yi, et al.
Publicado: (2022)

Adverse Reactions and Clinical Outcomes for Leukocyte-Poor Versus Leukocyte-Rich Platelet-Rich Plasma in Knee Osteoarthritis: A Systematic Review and Meta-analysis
por: Kim, Jun-Ho, et al.
Publicado: (2021)

Platelets Guide Leukocytes to Their Sites of Extravasation
por: Zuchtriegel, Gabriele, et al.
Publicado: (2016)

Therapeutics for rheumatic fever and rheumatic heart disease
por: Ralph, Anna P, et al.
Publicado: (2022)

Depression and anxiety in cancer patient enrolled in clinical trials with serious adverse events
por: Peng, Zhen, et al.
Publicado: (2023)

PLATELET PHAGOCYTOSIS AND AGGREGATION
por: Movat, Henry Z., et al.
Publicado: (1965)

Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update
por: Dang, Quang Minh, et al.
Publicado: (2023)

Surgical or Traumatic Rheumatism
Publicado: (1904)

Results of Surgical Ablation for Atrial Fibrillation in Patients with Rheumatic Heart Disease
por: Albacker, Turki B., et al.
Publicado: (2023)

THE OCCURRENCE OF LEUCOCYTE-PLATELET THROMBOSIS IN RHEUMATIC CARDITIS
por: Stetson, Chandler A.
Publicado: (1951)

Cannot write session to /tmp/vufind_sessions/sess_h8ecnhavcvmeeeo3bvm4u6kra2